Metropolis Healthcare Ltd.
Snapshot View

View in App

Prices View details >>

1299.70 +1.50 ▲0.1%

27 January 2023, 04:01:00 PM
Volume: 4,935

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.metropolisindia.com
Market Cap 6,628.45 Cr.
Enterprise Value(EV) 6,675.76 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 30.22 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 42.83 Trailing Twelve Months Ending 2022-09
Industry PE 46.72 Trailing Twelve Months Ending 2022-09
Book Value / Share 185.24 Trailing Twelve Months Ending 2022-09
Price to Book Value 6.99 Calculated using Price: 1,294.35
Dividend Yield 0.62 Period Ending 2022-03
No. of Shares Subscribed 5.12 Cr. 51,210,664 Shares
FaceValue 2
Company Profile
Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening. It classifies its tests into ‘routine' tests such as blood chemistry analyses, blood cell counts and urine examination; ‘semi-specialized' tests such as thyroid function tests, viral and bacterial cultures, histology, cytology and infectious disease tests; and ‘specialized' tests such as tests for coagulation studies, autoimmunity tests, cytogenetics and molecular diagnostics. It is focused on providing reliable test results as well as value-added services such as home collection of specimens and online access to test reports. It also offers customized wellness packages to its institutional customers as per their requirement.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.12%
1 Week
-0.70%
1 Month
-1.91%
3 Month
-21.70%
6 Month
-14.25%
1 Year
-46.99%
2 Year
-37.99%
5 Year
10 Year

Ratios View Details >>

8 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 18.77 26.16 36.47 30.38 30.17 27.33 30.07 27.31
Return on Capital Employed (%) 27.47 40.06 54.28 45.22 45.10 37.90 41.60 34.39
Return on Assets (%) 14.48 19.06 23.75 16.93 15.51 14.78 18.43 16.19

Balance Sheet View Details >>

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 361 265 323 415 419 524 707 886 957
Non Curr. Liab. 10 1 16 148 142 195 111 362 254
Curr. Liab. 75 105 152 233 241 210 240 342 289
Minority Int. 23 20 21 14 1 2 1 2 2
Equity & Liab. 468 391 512 810 803 930 1,059 1,593 1,502
Non Curr. Assets 167 166 227 367 381 492 415 1,159 1,177
Curr. Assets 302 225 285 443 422 438 645 434 326
Misc. Exp. not W/O
Total Assets 468 391 512 810 803 930 1,059 1,593 1,502

Profit Loss View Details >>

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 455 524 545 647 761 856 998 1,228 1,179
Other Income 6 22 26 8 8 9 12 18 16
Total Income 461 546 570 655 769 865 1,010 1,246 1,195
Total Expenditure -337 -388 -391 -469 -557 -619 -708 -880 -881
PBIDT 124 158 179 186 212 246 302 366 313
Interest -2 -2 -2 -4 -4 -13 -12 -25 -26
Depreciation -21 -21 -17 -19 -20 -39 -46 -63 -78
Taxation -33 -46 -53 -52 -63 -41 -61 -79 -55
Exceptional Items -8 -25 16
PAT 68 82 107 112 125 128 183 215 155
Minority Interest -7 -8 -8 -3 0 0 -1 -1
Share Associate -6 -1 -1
Other Related Items
Consolidated Net Profit 61 74 102 104 120 127 183 214 155
Adjusted EPS 62 77 107 109 24 25 36 42 30

Cash Flow View Details >>

Particulars 6 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 102 104 90 215 249 253
Cash Fr. Inv. -86 2 35 -105 62 -738
Cash Fr. Finan. -17 -87 -118 -55 -33 163
Net Change -1 19 7 55 278 -322
Cash & Cash Eqvt 26 43 51 107 387 66

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 50.39 50.38 50.37 50.33 49.50 49.79 49.79 49.76 49.76
Public 49.61 49.62 49.63 49.67 50.50 50.21 50.21 50.24 50.24
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 5.44 3.30 3.30 3.30 2.67 1.18 1.18 1.18 1.18

Announcements View Details >>

Mon, 23 Jan 2023
Intimation W.R.T Withdrawal Of Petition Filed By Operational Creditors
Pursuant to Point No.16(c) of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and as per the direction given by National Stock Exchange of India Limited (NSE) this is to inform you that the matter listed with National Company Law Tribunal Mumbai Bench Court -II (NCLT) namely Mr. Vinod Lath v/s Metropolis Healthcare Ltd and Dr. Bharat Gupta v/s M/s. Metropolis Healthcare Limited were amicably settled between the parties. Consequently the above-mentioned petitions have been withdrawn by respective petitioners and the said petitions have been disposed off by NCLT. The withdrawal order of NCLT is attached for your ready reference. Further please note that the Company is awaiting for certified copy of the said orders
Thu, 12 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
We enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for quarter ended December 31 2022 received from Link Intime India Private Limited Registrar & Share Transfer Agent of the Company.
Sun, 08 Jan 2023
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
The Nomination and Remuneration Committee of the Board of the Directors of the Company vide circular resolution dated January 07 2023 have approved the allotment of 4 372 (Four Thousand Three Hundred and Seventy-Two) Equity shares of Rs.2/- (Rupees Two Only) each at an exercise price of Rs. 2/- (Rupees Two Only) each aggregating to Rs. 8 744 (Rupees Eight Thousand Seven Hundred and Forty-Four Only) against the Restrictive Stock Units (RSU) vested in and exercised by the employees of the Company under the MHL- Restrictive Stock Unit Plan 2020.

Technical Scans View Details >>

Wed, 25 Jan 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,518.84 1,040.75 +0.1%
Divi's Laboratories Ltd. 88,552.35 3,385.55 +1.5%
Cipla Ltd. 83,862.25 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 69,879.98 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 60,777.77 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,497.96 1,537.85 -1.3%
Abbott India Ltd. 45,101.64 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.79 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.71 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 32.68 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 22.47 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.39 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 65.87 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.15 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.33 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 3.83 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.36 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.15 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.62 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.62 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Metropolis Healthcare Ltd.

What is Metropolis Health. share price?
Can I buy Metropolis Health. shares now?
What is the Dividend Yield of Metropolis Health.?
What is the Market Cap of Metropolis Health.?
What are the key metrics to analyse Metropolis Health.?
What is the 52 Week High and Low of Metropolis Health.?
What is the trend of Metropolis Health. share price?